Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluating the Bridge Device for Opioid Use Disorder Treatment
NCT04325659Phase 3Completed
- Sponsor
- Johns Hopkins University
- Start
- Nov 2020
- Primary completion
- Apr 2025
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in opioid use disorder (OUD) and opioid withdrawal (3 arms), sponsored by Johns Hopkins University. Primary endpoints: Number of Participants Retained at 5 days, Clinical Opiate Withdrawal Scale Peak Score at 5 days and 2 more. Started Nov 2020; status: completed.
02
Conditions
opioid use disorder (OUD)opioid withdrawal
Beyond the preview
Go deeper on NCT04325659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04325659.